GEORGE GORICH: Open Payments
NPI 1730125618 · CARMEL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,831 in 112 payments from 23 companies in 2025. Trend: 2023 $2,502 · 2024 $3,543 · 2025 $2,831
Food & beverage: $2,789Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $469 |
| Otsuka America Pharmaceutical, Inc. | 13 | $281 |
| Novo Nordisk Inc | 8 | $265 |
| ABBVIE INC. | 14 | $236 |
| PFIZER INC. | 14 | $233 |
| Collegium Pharmaceutical, Inc. | 10 | $179 |
| Madrigal Pharmaceuticals | 1 | $148 |
| Braeburn Inc. | 5 | $137 |
| GlaxoSmithKline, LLC. | 5 | $136 |
| Alkermes, Inc. | 4 | $121 |
Products named: REXULTI, MOUNJARO, VRAYLAR, Belbuca, REZDIFFRA, BRIXADI, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
